Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells

Experimental Eye Research

Volumn 90, Issue 3, 2010, Pages 444-451

  Albertsmeyer, Ann Christin ^a   Kakkassery, Vinodh ^a   Spurr Michaud, Sandra ^a   Beeks, Olivia ^a   Gipson, Ilene K ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Dry eye; IFN ; Membrane associated mucins; MUC1; MUC16; Ocular surface; TNF

Indexed keywords

AUTACOID; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; MUCIN; MUCIN 1; MUCIN 16; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; CORNEA CELL; DRY EYE; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION;

BLOTTING, WESTERN; CA-125 ANTIGEN; CELL LINE; CYTOKINES; EPITHELIUM, CORNEAL; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; MUCIN-1; RECEPTORS, CYTOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77649189365     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.12.009     Document Type: Article

References (41)

1. Afonso A.A., Monroy D., Stern M.E., Feuer W.J., Tseng S.C., Pflugfelder S.C. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology 1999, 106:803-810.
2. Argueso P., Spurr-Michaud S., Russo C.L., Tisdale A., Gipson I.K. MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. Invest. Ophthalmol. Vis. Sci. 2003, 44:2487-2495.
3. Blalock T., Spurr-Michaud S., Tisdale A., Heimer S., Gilmore M., Ramesh V., Gipson I. Functions of MUC16 in corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 2007, 48:4509-4518.
4. Blalock T.D., Spurr-Michaud S.J., Tisdale A.S., Gipson I.K. Release of membrane-associated mucins from ocular surface epithelia. Invest. Ophthalmol. Vis. Sci. 2008, 49:1864-1871.
5. Chabaud M., Lubberts E., Joosten L., van Den Berg W., Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res. 2001, 3:168-177.
6. Danjo Y., Watanabe H., Tisdale A.S., George M., Tsumura T., Abelson M.B., Gipson I.K. Alteration of mucin in human conjunctival epithelia in dry eye. Invest. Ophthalmol. Vis. Sci. 1998, 39:2602-2609.
7. De Paiva C.S., Villarreal A.L., Corrales R.M., Rahman H.T., Chang V.Y., Farley W.J., Stern M.E., Niederkorn J.Y., Li D.Q., Pflugfelder S.C. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest. Ophthalmol. Vis. Sci. 2007, 48:2553-2560.
8. De Paiva C.S., Chotikavanich S., Pangelinan S.B., Pitcher J.D., Fang B., Zheng X., Ma P., Farley W.J., Siemasko K.F., Niederkorn J.Y., Stern M.E., Li D.-Q., Pflugfelder S.C. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol 2009, 2:243-253.
9. DEWS Report of the international dry eye workshop (DEWS). Ocular Surface 2007, 5:67-202.
10. Eckert J., Niemann H. mRNA expression of leukaemia inhibitory factor (LIF) and its receptor subunits glycoprotein 130 and LIF-receptor-beta in bovine embryos derived in vitro or in vivo. Mol. Hum. Reprod. 1998, 4:957-965.
11. Galboiz Y., Shapiro S., Lahat N., Miller A. Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-gamma and -beta: implications to multiple sclerosis. J. Neuroimmunol 2002, 131:191-200.
12. Gerritsma J.S., Gerritsen A.F., De Ley M., van Es L.A., Daha M.R. Interferon-gamma induces biosynthesis of complement components C2, C4 and factor H by human proximal tubular epithelial cells. Cytokine 1997, 9:276-283.
13. Gipson I.K., Hori Y., Argueso P. Character of ocular surface mucins and their alteration in dry eye disease. Ocular Surface 2004, 2:131-148.
14. Gipson I.K., Spurr-Michaud S., Argueso P., Tisdale A., Ng T.F., Russo C.L. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest. Ophthalmol. Vis. Sci. 2003, 44:2496-2506.
15. 17 lineage. Curr. Opin. Immunol. 2006, 18:349-356.
16. Hoebler C., Gaudier E., De Coppet P., Rival M., Cherbut C. MUC genes are differently expressed during onset and maintenance of inflammation in dextran sodium sulfate-treated mice. Dig. Dis. Sci. 2006, 51:381-389.
17. Hollingsworth M.A., Swanson B.J. Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 2004, 4:45-60.
18. Itoh Y., Joh T., Tanida S., Sasaki M., Kataoka H., Itoh K., Oshima T., Ogasawara N., Togawa S., Wada T., Kubota H., Mori Y., Ohara H., Nomura T., Higashiyama S., Itoh M. IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. Cytokine 2005, 29:275-282.
19. Kikly K., Liu L., Na S., Sedgwick J.D. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 2006, 18:670-675.
20. Knofler M., Mosl B., Bauer S., Griesinger G., Husslein P. TNF-alpha/TNFRI in primary and immortalized first trimester cytotrophoblasts. Placenta 2000, 21:525-535.
21. Kullberg M.C., Jankovic D., Feng C.G., Hue S., Gorelick P.L., McKenzie B.S., Cua D.J., Powrie F., Cheever A.W., Maloy K.J., Sher A. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 2006, 203:2485-2494.
22. Lam H., Bleiden L., de Paiva C.S., Farley W., Stern M.E., Pflugfelder S.C. Tear cytokine profiles in dysfunctional tear syndrome. Am. J. Ophthalmol. 2009, 147:198-205. e191.
23. Lambiase A., Micera A., Mantelli F., Moretti C., Di Zazzo A., Perrella E., Bonini S., Bonini S. T-helper 17 lymphocytes in ocular cicatricial pemphigoid. Mol. Vis. 2009, 15:1449-1455.
24. Lemp M.A. Report of the national eye institute/industry workshop on clinical trials in dry eyes. CLAO J. 1995, 21:221-232.
25. Li X., Wang L., Nunes D.P., Troxler R.F., Offner G.D. Pro-inflammatory cytokines up-regulate MUC1 gene expression in oral epithelial cells. J. Dent. Res. 2003, 82:883-887.
26. 1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 2008, 205:799-810.
27. Maertzdorf J., Osterhaus A.D., Verjans G.M. IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J. Immunol. 2002, 169:5897-5903.
28. Nishida T., Nakamura M., Mishima H., Otori T. Interleukin 6 promotes epithelial migration by a fibronectin-dependent mechanism. J. Cell. Physiol. 1992, 153:1-5.
29. Path G., Bornstein S.R., Ehrhart-Bornstein M., Scherbaum W.A. Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis. J. Clin. Endocrinol. Metab. 1997, 82:2343-2349.
30. Paulsen F., Jager K., Worlitzsch D., Brauer L., Schulze U., Schafer G., Sel S. Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines. Ann. Anat. 2008, 190:59-70.
31. Pflugfelder S.C., Jones D., Ji Z., Afonso A., Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr. Eye Res. 1999, 19:201-211.
32. Prause O., Bozinovski S., Anderson G.P., Linden A. Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax 2004, 59:313-317.
33. Silverman M.D., Zamora D.O., Pan Y., Texeira P.V., Baek S.H., Planck S.R., Rosenbaum J.T. Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells. Invest. Ophthalmol. Vis. Sci. 2003, 44:1608-1615.
34. Solomon A., Dursun D., Liu Z., Xie Y., Macri A., Pflugfelder S.C. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest. Ophthalmol. Vis. Sci. 2001, 42:2283-2292.
35. Song X.J., Li D.Q., Farley W., Luo L.H., Heuckeroth R.O., Milbrandt J., Pflugfelder S.C. Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca. Invest. Ophthalmol. Vis. Sci. 2003, 44:4223-4229.
36. Spurr-Michaud S., Argüeso P., Gipson I. Assay of mucins in human tear fluid. Exp. Eye Res. 2007, 84:939-950.
37. Thathiah A., Blobel C.P., Carson D.D. Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. J. Biol. Chem. 2003, 278:3386-3394.
38. Thathiah A., Brayman M., Dharmaraj N., Julian J.J., Lagow E.L., Carson D.D. Tumor necrosis factor alpha stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell line. Endocrinology 2004, 145:4192-4203.
39. Thathiah A., Carson D.D. MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17. Biochem. J. 2004, 382:363-373.
40. Thornton D., Khan N., Sheehan D. Separation and identification of mucins and their glycoforms. Glycoprotein Methods and Protocols: The Mucins 2000, 77-85. Humana Press, Totowa. A.P. Corfield (Ed.).
41. Xiong T., Peng H., Chen G., Yuan Y. The expression and activity of MMPs are increased in residual tumor tissues after the termination of immunotherapy. J. Huazhong Univ. Sci. Technol. Medical sciences = Hua zhong ke ji daxue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao 2008, 28:375-378.